ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RALPH CONAWAY LANUZA M.D.

AVE ROOSEVELT # 400 CLINICA LAS AMERICA SUITE 203

Hato rey | Puerto Rico | 00918

(787) 763-9468

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,789Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 384

$372K Total Retail Price of All Prescriptions

Rank: 89 out of 384

525 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,295 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 714 669 1 1
AMLODIPINE BESYLATE 530 471 2 3
ATENOLOL 377 352 3 12
LOSARTAN POTASSIUM 371 355 4 5
ENALAPRIL MALEATE 335 309 5 6
SYNTHROID 325 322 6 9
LOSARTAN-HYDROCHLOROTHIAZIDE 220 206 7 10
METFORMIN HCL 194 176 8 2
METOPROLOL SUCCINATE 178 171 9 21
GABAPENTIN 173 167 10 4
LEVOTHYROXINE SODIUM 162 148 11 11
PANTOPRAZOLE SODIUM 147 125 12 39
HYDROCHLOROTHIAZIDE 145 145 13 16
OMEPRAZOLE 136 130 14 8
METOPROLOL TARTRATE 134 125 15 15
ATORVASTATIN CALCIUM 125 118 16 22
CRESTOR 121 109 17 45
ZOLPIDEM TARTRATE 110 104 18 19
GLIMEPIRIDE 107 106 19 18
FUROSEMIDE 101 91 20 17
DIOVAN 100 100 21 54
LISINOPRIL 96 79 22 14
PRAVASTATIN SODIUM 94 83 23 24
PLAVIX 91 79 24 32
VERAPAMIL ER 89 87 25 41
EVISTA 86 80 26 52
CARVEDILOL 85 85 27 23
SERTRALINE HCL 82 82 28 26
CLOPIDOGREL 82 74 28 30
ISOSORBIDE MONONITRATE ER 82 70 28 28
ALENDRONATE SODIUM 80 79 31 20
NIFEDIPINE ER 74 62 32 106
RANITIDINE HCL 72 70 33 7
TRICOR 72 70 33 123
CLONIDINE HCL 70 70 35 84
DIGOXIN 70 70 35 49
WARFARIN SODIUM 69 67 37 48
TAMSULOSIN HCL 68 68 38 25
NAMENDA 65 65 39 67
DIOVAN HCT 57 57 40 66
RAMIPRIL 55 53 41 51
AMLODIPINE BESYLATE-BENAZEPRIL 55 55 41 43
GLIPIZIDE 50 44 43 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.